NIP
NDRM

Nicholas Investment Partners’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Nicholas Investment Partners’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-58,999
Closed -$1.09M – 378
2016
Q3 		$1.09M Buy
58,999
+18,631
+46% +$323K 0.07% 284
2016
Q2 		$656K Buy
+40,368
New +$680K 0.05% 290

Other funds holding NDRM

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nicholas Investment Partners's NDRM Position: Q4 2016 in Review

Nicholas Investment Partners sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2016, closing a stake of 58,999 shares — an estimated $1.09M sold.

Nicholas Investment Partners first reported a position in NDRM in Q2 2016 and held it in 2 quarters. The position peaked at $1.09M in Q3 2016. 56 funds tracked by Wall St. Rank hold NDRM as of Q4 2016.

  • Nicholas Investment Partners reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2016 after selling out during the quarter.
  • Nicholas Investment Partners sold 58,999 NeuroDerm Ltd. Ordinary Shares shares in Q4 2016, an estimated $1.09M.
  • Nicholas Investment Partners first reported a position in NeuroDerm Ltd. Ordinary Shares in Q2 2016 and held it in 2 quarters.
  • Nicholas Investment Partners's NeuroDerm Ltd. Ordinary Shares position peaked at $1.09M in Q3 2016.
  • 56 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2016.

Based on Nicholas Investment Partners's 13F filing for Q4 2016, filed 10 Feb 2017.